HS
NAGE

Horan Securities’s Niagen Bioscience NAGE Stock Holding History

Horan Securities’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,210
Closed -$7K – 382
2020
Q1 		$7K Buy
+2,210
New +$8.49K 0.01% 152
2019
Q4 		– Sell
-2,210
Closed -$9K – 236
2019
Q3 		$9K Hold
2,210
– – 0.01% 169
2019
Q2 		$10K Hold
2,210
– – 0.01% 177
2019
Q1 		$9K Hold
2,210
– – 0.01% 152
2018
Q4 		$8K Hold
2,210
– – 0.01% 153
2018
Q3 		$8K Hold
2,210
– – 0.01% 135
2018
Q2 		$9K Hold
2,210
– – 0.01% 130
2018
Q1 		$9K Buy
2,210
+960
+77% +$5.03K 0.01% 122
2017
Q4 		$8K Buy
1,250
+160
+15% +$864 0.01% 128
2017
Q3 		$5K Hold
1,090
– – ﹤0.01% 152
2017
Q2 		$4K Hold
1,090
– – ﹤0.01% 151
2017
Q1 		$3K Buy
+1,090
New +$3.09K ﹤0.01% 161

Other funds holding NAGE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SA
Sycale Advisors New York $201M AUM 2.35% 1-Year Est. Return

Horan Securities's NAGE Position: Q2 2020 in Review

Horan Securities sold out of Niagen Bioscience (NAGE) in Q2 2020, closing a stake of 2,210 shares — an estimated $7K sold.

Horan Securities first reported a position in NAGE in Q1 2017 and held it in 12 quarters. The position peaked at $10K in Q2 2019. 66 funds tracked by Wall St. Rank hold NAGE as of Q2 2020.

  • Horan Securities reported no remaining Niagen Bioscience position as of Q2 2020 after selling out during the quarter.
  • Horan Securities sold 2,210 Niagen Bioscience shares in Q2 2020, an estimated $7K.
  • Horan Securities first reported a position in Niagen Bioscience in Q1 2017 and held it in 12 quarters.
  • Horan Securities's Niagen Bioscience position peaked at $10K in Q2 2019.
  • 66 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2020.

Based on Horan Securities's 13F filing for Q2 2020, filed 11 Aug 2020.